Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function

Am J Obstet Gynecol. 2007 Jul;197(1):40.e1-6. doi: 10.1016/j.ajog.2007.02.015.

Abstract

Objective: This study was undertaken to compare the effects of exposure to repeated courses of antenatal steroids with those of a single course on hypothalamic-pituitary-adrenal axis function.

Study design: Women at risk of premature delivery were assessed for entry into a randomized controlled trial of repeated courses of corticosteroids (ACTORDS). If a woman declined the randomized trial then consent was sought for collection of observational data. Baseline bloods for cortisol and adrenocorticotropic hormone levels were collected and in a subset of infants a metyrapone test performed.

Results: In the 86 studied infants, cortisol and adrenocorticotropic hormone levels did not differ between those exposed to single and repeated courses of antenatal steroids (P = .53 and P = .15, respectively). Although cortisol levels fell in response to metyrapone (P = .03) this response was not different between the single and repeated course groups (P = .46).

Conclusion: Repeated courses of antenatal steroids do not cause important hypothalamic-pituitary-adrenal axis suppression in the neonate.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Birth Weight
  • Double-Blind Method
  • Female
  • Gestational Age
  • Glucocorticoids / administration & dosage*
  • Humans
  • Hydrocortisone / blood
  • Hypothalamo-Hypophyseal System / drug effects*
  • Infant, Newborn
  • Obstetric Labor, Premature / drug therapy
  • Pituitary-Adrenal System / drug effects*
  • Pregnancy
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Adrenocorticotropic Hormone
  • Hydrocortisone